The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Beyond natural antibodies: the power of in vitro display technologies
Open accessAbstract
In vitro display technologies, best exemplified by phage and yeast display, were first described for the selection of antibodies some 20 years ago. Since then, many antibodies have been selected and improved upon using these methods. Although it is not widely recognized, many of the antibodies derived using in vitro display methods have properties that would be extremely difficult, if not impossible, to obtain by immunizing animals. The first antibodies derived using in vitro display methods are now in the clinic, with many more waiting in the wings. Unlike immunization, in vitro display permits the use of defined selection conditions and provides immediate availability of the sequence encoding the antibody. The amenability of in vitro display to high-throughput applications broadens the prospects for their wider use in basic and applied research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Self-citationSearching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
Yeast surface display for screening combinatorial polypeptide libraries
Boder, E. T., & Wittrup, K. D. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-553 · Cited by 1,760
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Self-citationSui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli
Skerra, A., & Plückthun, A. (1988) · Science · doi:10.1126/science.3285470 · Cited by 978
Isolating and engineering human antibodies using yeast surface display
Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., & Wittrup, K. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.94 · Cited by 909
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
Ridgway, J. B. B., Presta, L. G., & Carter, P. (1996) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/9.7.617 · Cited by 810
Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., & Lerner, R. A. (1989) · Science · doi:10.1126/science.2531466 · Cited by 805
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
Therapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 720
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
Orlandi, R., Güssow, D. H., Jones, P. T., & Winter, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3833 · Cited by 706
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
Boder, E. T., Midelfort, K. S., & Wittrup, K. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170297297 · Cited by 673
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
The fibronectin type III domain as a scaffold for novel binding proteins
Koide, A., Bailey, C. W., Huang, X., & Koide, S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2238 · Cited by 585
Feldhaus, M. J., Siegel, R. W., Opresko, L. K., Coleman, J. R., Feldhaus, J. M. W., Yeung, Y. A., Cochran, J. R., Heinzelman, P., Colby, D., Swers, J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt785 · Cited by 520
An efficient route to human bispecific IgG
Merchant, A. M., Zhu, Z., Yuan, J. Q., Goddard, A., Adams, C. W., Presta, L. G., & Carter, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-677 · Cited by 510
Batista, F. D., & Neuberger, M. S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80580-4 · Cited by 481
A microengraving method for rapid selection of single cells producing antigen-specific antibodies
Love, J. C., Ronan, J. L., Grotenbreg, G. M., van der Veen, A. G., & Ploegh, H. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1210 · Cited by 456
A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding
Sako, D., Comess, K. M., Barone, K. M., Camphausen, R. T., Cumming, D. A., & Shaw, G. D. (1995) · Cell · doi:10.1016/0092-8674(95)90173-6 · Cited by 434
Design and Use of a Phage Display Library
Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., & Neri, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21769 · Cited by 422
Kreitman, R. J., Wilson, W. H., White, J. D., Stetler-Stevenson, M., Jaffe, E. S., Giardina, S., Waldmann, T. A., & Pastan, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1622 · Cited by 420
Fluorogen-activating single-chain antibodies for imaging cell surface proteins
Szent-Gyorgyi, C., Schmidt, B. F., Creeger, Y., Fisher, G. W., Zakel, K. L., Adler, S., Fitzpatrick, J. A. J., Woolford, C. A., Yan, Q., Vasilev, K. V., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1368 · Cited by 390
Schier, R., McCall, A., Adams, G. P., Marshall, K. W., Merritt, H., Yim, M., Crawford, R. S., Weiner, L. M., Marks, C., & Marks, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0598 · Cited by 382
Hanes, J., Schaffitzel, C., Knappik, A., & Plückthun, A. (2000) · Nature Biotechnology · doi:10.1038/82407 · Cited by 373
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Bostrom, J., Yu, S.-F., Kan, D., Appleton, B. A., Lee, C. V., Billeci, K., Man, W., Peale, F., Ross, S., Wiesmann, C., et al. (2009) · Science · doi:10.1126/science.1165480 · Cited by 370
Fellouse, F. A., Esaki, K., Birtalan, S., Raptis, D., Cancasci, V. J., Koide, A., Jhurani, P., Vasser, M., Wiesmann, C., Kossiakoff, A. A., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.005 · Cited by 358
Self-citationLiang, W.-C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., Fu, L., Malik, A. K., Gerber, H.-P., Ferrara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508199200 · Cited by 346
Computational design of antibody-affinity improvement beyond in vivo maturation
Lippow, S. M., Wittrup, K. D., & Tidor, B. (2007) · Nature Biotechnology · doi:10.1038/nbt1336 · Cited by 342
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Yang, W.-P., Green, K., Pinz-Sweeney, S., Briones, A. T., Burton, D. R., & Barbas III, C. F. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0626 · Cited by 333
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
Nowakowski, A., Wang, C., Powers, D. B., Amersdorfer, P., Smith, T. J., Montgomery, V. A., Sheridan, R., Blake, R., Smith, L. A., & Marks, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172229899 · Cited by 331
Hu, S., Shively, L., Raubitschek, A. A., Sherman, M. A., Williams, L. E., Wong, J. Y., Shively, J. E., & Wu, A. M. (1996) · PubMed · Cited by 330
Glycosylation engineering in yeast: the advent of fully humanized yeast
Hamilton, S. R., & Gerngross, T. U. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.09.001 · Cited by 322
Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target
Zahnd, C., Amstutz, P., & Plückthun, A. (2007) · Nature Methods · doi:10.1038/nmeth1003 · Cited by 308
Fellouse, F. A., Wiesmann, C., & Sidhu, S. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401786101 · Cited by 306
Self-citationA surface expression vector for antibody screening
Breitling, F., Dübel, S., Seehaus, T., Klewinghaus, I., & Little, M. (1991) · Gene · doi:10.1016/0378-1119(91)90244-6 · Cited by 305
Self-citationA Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
Martens, T., Schmidt, N.-O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., Westphal, M., & Lamszus, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1418 · Cited by 305
Alternative non-antibody scaffolds for molecular recognition
Skerra, A. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.04.010 · Cited by 300
Antibodies from phage antibody libraries
Bradbury, A. R. M., & Marks, J. D. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.007 · Cited by 296
Self-citationReddy, S. T., Ge, X., Miklos, A. E., Hughes, R. A., Kang, S. H., Hoi, K. H., Chrysostomou, C., Hunicke-Smith, S. P., Iverson, B. L., Tucker, P. W., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1673 · Cited by 292
The Sulfinator: predicting tyrosine sulfation sites in protein sequences
Monigatti, F., Gasteiger, E., Bairoch, A., & Jung, E. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.5.769 · Cited by 292
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
Maynard, J. A., Maassen, C. B. M., Leppla, S. H., Brasky, K., Patterson, J. L., Iverson, B. L., & Georgiou, G. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-597 · Cited by 287
Jin, A., Ozawa, T., Tajiri, K., Obata, T., Kondo, S., Kinoshita, K., Kadowaki, S., Takahashi, K., Sugiyama, T., Kishi, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.1966 · Cited by 261
Molecular engineering and design of therapeutic antibodies
Presta, L. G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.012 · Cited by 250
Beck, A., Wagner-Rousset, E., Bussat, M.-C., Lokteff, M., Klinguer-Hamour, C., Haeuw, J.-F., Goetsch, L., Wurch, T., Dorsselaer, A., & Corvaia, N. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786411 · Cited by 246
Application of phage display to high throughput antibody generation and characterization
Schofield, D. J., Pope, A. R., Clementel, V., Buckell, J., Chapple, S. D., Clarke, K. F., Conquer, J. S., Crofts, A. M., Crowther, S. R., Dyson, M. R., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r254 · Cited by 236
Self-citationJespers, L. S., Roberts, A., Mahler, S. M., Winter, G., & Hoogenboom, H. R. (1994) · Nature Biotechnology · doi:10.1038/nbt0994-899 · Cited by 233
Villa, A., Trachsel, E., Kaspar, M., Schliemann, C., Sommavilla, R., Rybak, J., Rösli, C., Borsi, L., & Neri, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23408 · Cited by 228
Lee, C. V., Liang, W.-C., Dennis, M. S., Eigenbrot, C., Sidhu, S. S., & Fuh, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.051 · Cited by 227
Self-citationCrystal structure of full-length KcsA in its closed conformation
Uysal, S., Vásquez, V., Tereshko, V., Esaki, K., Fellouse, F. A., Sidhu, S. S., Koide, S., Perozo, E., & Kossiakoff, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810663106 · Cited by 224
Self-citationHigh avidity scFv multimers; diabodies and triabodies
Hudson, P. J., & Kortt, A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00157-x · Cited by 219
Phage display systems and their applications
Paschke, M. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0270-9 · Cited by 208
Sastry, L., Alting-Mees, M., Huse, W. D., Short, J. M., Sorge, J. A., Hay, B. N., Janda, K. D., Benkovic, S. J., & Lerner, R. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5728 · Cited by 199
Krogsgaard, M., Wucherpfennig, K. W., Canella, B., Hansen, B. E., Svejgaard, A., Pyrdol, J., Ditzel, H., Raine, C., Engberg, J., & Fugger, L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1395 · Cited by 197
Li, K., Li, Y., Wu, W., Gordon, W. R., Chang, D. W., Lu, M., Scoggin, S., Fu, T., Vien, L., Histen, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800170200 · Cited by 195
Selection of tumor-specific internalizing human antibodies from phage libraries
Poul, M.-A., Becerril, B., Nielsen, U. B., Morisson, P., & Marks, J. D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4026 · Cited by 192
Crystal structure of a diabody, a bivalent antibody fragment
Perisic, O., Webb, P. A., Holliger, P., Winter, G., & Williams, R. L. (1994) · Structure · doi:10.1016/s0969-2126(94)00123-5 · Cited by 189
An open letter to our readers on the use of antibodies
Saper, C. B. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20839 · Cited by 187
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Garcia-Rodriguez, C., Levy, R., Arndt, J. W., Forsyth, C. M., Razai, A., Lou, J., Geren, I., Stevens, R. C., & Marks, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1269 · Cited by 177
Nielsen, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Refaat Shalaby, M., Shao, Y., Benz, C. C., & Marks, J. D. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00256-2 · Cited by 177
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Jensen, B. C., Swigart, P. M., & Simpson, P. C. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-008-0368-6 · Cited by 176
Selection of antibodies for intracellular function using a two-hybrid in vivo system
Visintin, M., Tse, E., Axelson, H., Rabbitts, T. H., & Cattaneo, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11723 · Cited by 176
Engineered proteins as specific binding reagents
Binz, H. K., & Plückthun, A. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.06.005 · Cited by 173
Larrick, J. W., Danielsson, L., Brenner, C. A., Abrahamson, M., Fry, K. E., & Borrebaeck, C. A. K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80138-x · Cited by 171
Hayhurst, A., Happe, S., Mabry, R., Koch, Z., Iverson, B. L., & Georgiou, G. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00100-5 · Cited by 165
Persic, L., Roberts, A., Wilton, J., Cattaneo, A., Bradbury, A., & Hoogenboom, H. R. (1997) · Gene · doi:10.1016/s0378-1119(96)00628-2 · Cited by 162
Self-citationDadaglio, G., Nelson, C. A., Deck, M. B., Petzold, S. J., & Unanue, E. R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80448-3 · Cited by 160
Stepwise in vitro affinity maturation of Vitaxin, an α v β 3 -specific humanized mAb
Wu, H., Beuerlein, G., Nie, Y., Smith, H., Lee, B. A., Hensler, M. E., Huse, W. D., & Watkins, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6037 · Cited by 156
Intracellular expression of single chain antibodies reverts ErbB-2 transformation.
Beerli, R. R., Wels, W. S., & Hynes, N. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51027-4 · Cited by 155
A human scFv antibody generation pipeline for proteome research
Hust, M., Meyer, T., Voedisch, B., Rülker, T., Thie, H., El-Ghezal, A., Kirsch, M. I., Schütte, M., Helmsing, S., Meier, D., et al. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.09.945 · Cited by 150
Self-citationSpecific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Grimsey, N. L., Goodfellow, C. E., Scotter, E. L., Dowie, M. J., Glass, M., & Graham, E. S. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.02.014 · Cited by 144
Jositsch, G., Papadakis, T., Haberberger, R. V., Wolff, M., Wess, J., & Kummer, W. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0365-9 · Cited by 143
Recombinant Antibodies to the Small GTPase Rab6 as Conformation Sensors
Nizak, C., Monier, S., Nery, E. D., Moutel, S., Goud, B., & Perez, F. (2003) · Science · doi:10.1126/science.1083911 · Cited by 142
Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A
Razai, A., Garcia-Rodriguez, C., Lou, J., Geren, I. N., Forsyth, C. M., Robles, Y., Tsai, R. M., Smith, T. J., Smith, L. A., Siegel, R. W., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.003 · Cited by 142
Lloyd, C., Lowe, D., Edwards, B. M., Welsh, F., Dilks, T., Hardman, C. H., & Vaughan, T. J. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzn058 · Cited by 142
Amstutz, P., Binz, H. K., Parizek, P., Stumpp, M. T., Kohl, A., Grütter, M. G., Forrer, P., & Plückthun, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501746200 · Cited by 137
Bispecific Antibodies for Cancer Immunotherapy: Current Perspectives
Müller, D., & Kontermann, R. E. (2010) · BioDrugs · doi:10.2165/11530960-000000000-00000 · Cited by 137
Synthetic antibodies for specific recognition and crystallization of structured RNA
Ye, J., Tereshko, V. A., Frederiksen, J. K., Koide, A., Fellouse, F. A., Sidhu, S. S., Koide, S., Kossiakoff, A. A., & Piccirilli, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709082105 · Cited by 132
Self-citationTherapeutic antibodies elicited by immunization against TNF-α
Dalum, I., Butler, D. M., Jensen, M. R., Hindersson, P., Steinaa, L., Waterston, A. M., Grell, S. N., Feldmann, M., Elsner, H. I., & Mouritsen, S. (1999) · Nature Biotechnology · doi:10.1038/10878 · Cited by 129
Le Gall, F., Kipriyanov, S. M., Moldenhauer, G., & Little, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00713-9 · Cited by 128
β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptide
Paganetti, P., Calanca, V., Galli, C., Stefani, M., & Molinari, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410047 · Cited by 115
Edwards, B. M., Barash, S. C., Main, S. H., Choi, G. H., Minter, R., Ullrich, S. J., Williams, E. M., Fou, L. D., Wilton, J., Albert, V. R., et al. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.054 · Cited by 111
A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm
Philibert, P., Stoessel, A., Wang, W., Sibler, A., Bec, N., Larroque, C., Saven, J. G., Courtête, J., Weiss, É., & Martineau, P. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-81 · Cited by 110
Intracellular immunization: antibody targeting to subcellular compartments
Biocca, S., & Cattaneo, A. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89019-4 · Cited by 108
Heitner, T., Moor, A. C. E., Garrison, J. L., Marks, C. B., Hasan, T. G., & Marks, J. D. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00340-9 · Cited by 105
Generating recombinant antibodies to the complete human proteome
Dübel, S., Stoevesandt, O., Taussig, M., & Hust, M. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.05.001 · Cited by 102
Self-citationIntracellular Immunization with Cytosolic Recombinant Antibodies
Biocca, S., Pierandrei‐Amaldi, P., Campioni, N., & Cattaneo, A. (1994) · Nature Biotechnology · doi:10.1038/nbt0494-396 · Cited by 99
Antibody-based targeting of the tumor vasculature
Schliemann, C., & Neri, D. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.08.002 · Cited by 99
From rodent reagents to human therapeutics using antibody guided selection
Osbourn, J. K., Groves, M. A. T., & Vaughan, T. J. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.006 · Cited by 97
Kehoe, J. W., Velappan, N., Walbolt, M., Rasmussen, J., King, D., Lou, J., Knopp, K. A., Pavlik, P., Marks, J. D., Bertozzi, C. R., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600314-mcp200 · Cited by 94
Self-citationKirsch, M. I., Hülseweh, B., Nacke, C., Rülker, T., Schirrmann, T., Marschall, H. ‐., Hust, M., & Dübel, S. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-66 · Cited by 93
Self-citationde Kruif, J., & Logtenberg, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7630 · Cited by 93
der Maur, A. A., Zahnd, C., Fischer, F., Spinelli, S., Honegger, A., Cambillau, C., Escher, D., Plückthun, A., & Barberis, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205264200 · Cited by 90
Allosteric Inhibition of Aminoglycoside Phosphotransferase by a Designed Ankyrin Repeat Protein
Kohl, A., Amstutz, P., Parizek, P., Binz, H. K., Briand, C., Capitani, G., Forrer, P., Plückthun, A., & Grütter, M. G. (2005) · Structure · doi:10.1016/j.str.2005.04.020 · Cited by 89
Hoffhines, A. J., Damoc, E., Bridges, K. G., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609398200 · Cited by 88
Sun, L., Lu, X., Li, C., Wang, M., Liu, Q., Li, Z., Hu, X., Li, J., Liu, F., Li, Q., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005476 · Cited by 87
Two-state selection of conformation-specific antibodies
Gao, J., Sidhu, S. S., & Wells, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812952106 · Cited by 86
Self-citationPei, X. Y., Holliger, P., Murzin, A. G., & Williams, R. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9637 · Cited by 81
Roth, A., Drummond, D. C., Conrad, F., Hayes, M. E., Kirpotin, D. B., Benz, C. C., Marks, J. D., & Liu, B. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0140 · Cited by 80
Cloutier, S. M., Couty, S., Terskikh, A. V., Marguerat, L., Crivelli, V., Pugnière, M., Mani, J. C., Leisinger, H., Mach, J. P., & Deperthes, D. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(01)00023-2 · Cited by 78
Automated Screening Procedure for High-Throughput Generation of Antibody Fragments
Hallborn, J., & Carlsson, R. N. K. (2002) · BioTechniques · doi:10.2144/dec02-hallborn · Cited by 78
Eisenhardt, S. U., Schwarz, M., Bassler, N., & Peter, K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.455 · Cited by 77
Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization
Marks, J. D. (2004) · Movement Disorders · doi:10.1002/mds.20023 · Cited by 72
Kinetics of interactions between antibodies and haptens
Smith, T. W., & Skubitz, K. M. (1975) · Biochemistry · doi:10.1021/bi00678a023 · Cited by 69
Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids
Grünewald, J., Hunt, G. S., Dong, L., Niessen, F., Wen, B. G., Tsao, M., Perera, R., Kang, M., Laffitte, B. A., Azarian, S. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900507106 · Cited by 67
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells
Lee, C. V., Hymowitz, S. G., Wallweber, H. J. A., et al. (2006) · Blood · doi:10.1182/blood-2006-03-011031 · Cited by 67
Antigen‐independent selection of stable intracellular single‐chain antibodies
der Maur, A. A., Escher, D., & Barberis, A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03101-5 · Cited by 65
Chames, P., Coulon, S., & Baty, D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5421 · Cited by 64
Pozner-Moulis, S., Cregger, M. A., Camp, R. L., & Rimm, D. L. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700515 · Cited by 61
Mabry, R. L., Rani, M., Geiger, R., Hubbard, G. B., Carrion, R., Brasky, K. M., Patterson, J. L., Georgiou, G., & Iverson, B. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8362-8368.2005 · Cited by 61
Intrabodies as therapeutic agents
Kontermann, R. E. (2004) · Methods · doi:10.1016/j.ymeth.2004.04.002 · Cited by 58
Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display
Pershad, K., Pavlovic, J. D., Gräslund, S., Nilsson, P., Colwill, K., Karatt-Vellatt, A., Schofield, D. J., Dyson, M. R., Pawson, T. J., Kay, B. K., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq003 · Cited by 57
Self-citationGriep, R. A., van Twisk, C., Kerschbaumer, R. J., Harper, K., Torrance, L., Himmler, G., van der Wolf, J. M., & Schots, A. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1041 · Cited by 55
Directing phage selections towards specific epitopes
Parsons, H. L., Earnshaw, J. C., Wilton, J., Johnson, K. S., Schueler, P. A., Mahoney, W. C., & McCafferty, J. (1996) · Protein Engineering Design and Selection · doi:10.1093/protein/9.11.1043 · Cited by 53
Self-citationAntibody-Based Vascular Tumor Targeting
Schliemann, C., & Neri, D. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_12 · Cited by 52
Röthlisberger, D., Pos, K. M., & Plückthun, A. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00359-x · Cited by 51
Cohen, C. J., Denkberg, G., Lev, A., Epel, M., & Reiter, Y. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.640 · Cited by 50
Effector mechanisms of therapeutic antibodies against ErbB receptors
Peipp, M., Dechant, M., & Valerius, T. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.012 · Cited by 48
Antibodies to steroids from a small human naive IgM library
Dörsam, H., Rohrbach, P., Kürschner, T., Kipriyanov, S. M., Renner, S., Braunagel, M., Welschof, M., & Little, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00966-6 · Cited by 48
Stryhn, A., Andersen, P. S., Pedersen, L. Ø., Svejgaard, A., Holm, A., Thorpe, C. J., Fugger, L. H., Buus, S., & Engberg, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10338 · Cited by 45
Rizk, S. S., Łuchniak, A., Uysal, S., Brawley, C. M., Rock, R. S., & Kossiakoff, A. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904907106 · Cited by 44
Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs
Hemminki, A., Niemi, S., Hautoniemi, L., Söderlund, H., & Takkinen, K. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00002-5 · Cited by 39
Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer
Liu, B., Conrad, F., Roth, A., Drummond, D. C., Simko, J. P., & Marks, J. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0208-z · Cited by 39
Watanabe, H., Nakanishi, T., Umetsu, M., & Kumagai, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805547200 · Cited by 38
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism
Dobson, C., Main, S. H., Newton, P., Chodorge, M., Cadwallader, K. A., Humphreys, R. C., Albert, V. R., Vaughan, T. J., Minter, R., & Edwards, B. M. (2009) · mAbs · doi:10.4161/mabs.1.6.10057 · Cited by 37
Velappan, N., Martinez, J. S., Valero, R., Chasteen, L., Ponce, L., Bondu, V., Kelly, C., Pavlik, P., Hjelle, B. L., & Bradbury, A. M. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.01.011 · Cited by 33
Self-citationMultimerization domains for antibody phage display and antibody production
Thie, H., Binius, S., Schirrmann, T., Hust, M., & Dübel, S. (2009) · New Biotechnology · doi:10.1016/j.nbt.2009.07.005 · Cited by 32
Self-citationSpecificity tuning of antibody fragments to neutralize two human chemokines with a single agent
Fagète, S., Ravn, U., Gueneau, F., Magistrelli, G., Kosco‐Vilbois, M. H., & Fischer, N. (2009) · mAbs · doi:10.4161/mabs.1.3.8527 · Cited by 29
Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies
Strebe, N., Guse, A., Schüngel, M., Schirrmann, T., Hafner, M., Jostock, T., Hust, M., Müller, W., & Dübel, S. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.012 · Cited by 26
Self-citationPope, A. R., Pritchard, K., Williams, A., et al. (1996) · Immunotechnology · doi:10.1016/s1380-2933(96)00051-6 · Cited by 14
Xiang, J. (1999) · Human Antibodies · doi:10.3233/hab-1999-9103 · Cited by 12
Cited by
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
The promise and challenge of high-throughput sequencing of the antibody repertoire
Georgiou, G., Ippolito, G. C., Beausang, J., Busse, C. E., Wardemann, H., & Quake, S. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2782 · Cited by 652
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
The CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494
Metadata
- Authors
- Bradbury, A. R. M., Sidhu, S., Dübel, S., & McCafferty, J.
- Venue
- Nature Biotechnology
- Published
- 2011-03
- Volume
- 29
- Issue
- 3
- Pages
- 245-254
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2164148151
- Cited by
- 545
- References
- 134
- FWCI
- 32.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.